MedPath

Sung Lee Kyu

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:5

Trial Phases

2 Phases

Phase 4:3
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 4
3 (60.0%)
Not Applicable
2 (40.0%)

Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia

Not Applicable
Completed
Conditions
Benign Prostatic Hypertrophy With Outflow Obstruction
Overactive Detrusor
First Posted Date
2013-01-31
Last Posted Date
2019-12-02
Lead Sponsor
KYU-SUNG LEE
Target Recruit Count
184
Registration Number
NCT01781117
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Efficacy and Safety of Extracorporeal Biofeedback

Not Applicable
Completed
Conditions
Female Stress Urinary Incontinence
First Posted Date
2009-05-29
Last Posted Date
2019-12-02
Lead Sponsor
KYU-SUNG LEE
Target Recruit Count
100
Registration Number
NCT00910338
Locations
🇰🇷

Samsung Medical Center, Irwon-dong, Korea, Republic of

🇰🇷

Asan Medical Center, Ulsan College of Medicine, Seoul, Korea, Republic of

A Study to Evaluate Add on Effect of Solifenacin in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 Weeks

Phase 4
Completed
Conditions
Overactive Bladder
Interventions
First Posted Date
2009-04-20
Last Posted Date
2016-01-07
Lead Sponsor
KYU-SUNG LEE
Target Recruit Count
307
Registration Number
NCT00884104

Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients

Phase 4
Completed
Conditions
Overactive Bladder
Interventions
First Posted Date
2008-08-08
Last Posted Date
2019-12-02
Lead Sponsor
KYU-SUNG LEE
Target Recruit Count
173
Registration Number
NCT00730535
Locations
🇰🇷

Samsung Medical Center, Irwon-dong, Seoul, Korea, Republic of

🇰🇷

Holy Family Hospital, The Catholic University of Korea, Gyeonggi-do, Korea, Republic of

🇰🇷

Asan Medical Center, Ulsan College of Medicine, Seoul, Korea, Republic of

and more 1 locations

A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive Bladder

Phase 4
Completed
Conditions
Urinary Bladder, Overactive
Interventions
Drug: Alpha blocker
Drug: placebo
First Posted Date
2008-06-17
Last Posted Date
2016-01-07
Lead Sponsor
KYU-SUNG LEE
Target Recruit Count
94
Registration Number
NCT00699049

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.